住院COPD患者无创肺通气

IF 0.2 Q4 MEDICINE, GENERAL & INTERNAL
S. Avdeev
{"title":"住院COPD患者无创肺通气","authors":"S. Avdeev","doi":"10.20538/1682-0363-2017-2-6-19","DOIUrl":null,"url":null,"abstract":"The use of noninvasive ventilation (NIV) of lungs during the last two decades significantly improved the results of management of severe COPD patients with acute or chronic respiratory failure during both periods of exacerbation and stability. At present, NIV is considered to be the first-line therapy for acute exacerbation of COPD with hypercapnia and respiratory acidosis. This method of airway support turned out to be effective in patients after extubation both for the relief of excommunication from a respirator and for prophylaxis and treatment of postextubation respiratory failure. NIV was proven to be successful in patients with a combination of COPD and obstructive sleep apnea (overlap syndrome), in COPD with pneumonia and in postoperative COPD patients who have undergone lung resectional surgery. The efficacy of NIV under intensive care and intensive therapy unit conditions has stimulated the interest to the use of mask ventilation in hospitals and out-patient departments (for a prolonged domestic therapy). This article presents a review of NIV use in patients with COPD during both periods of exacerbation and stability.","PeriodicalId":43691,"journal":{"name":"Byulleten Sibirskoy Meditsiny","volume":null,"pages":null},"PeriodicalIF":0.2000,"publicationDate":"2017-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"8","resultStr":"{\"title\":\"Неинвазивная вентиляция легких у больных ХОБЛ, госпитализированных в стационар\",\"authors\":\"S. Avdeev\",\"doi\":\"10.20538/1682-0363-2017-2-6-19\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The use of noninvasive ventilation (NIV) of lungs during the last two decades significantly improved the results of management of severe COPD patients with acute or chronic respiratory failure during both periods of exacerbation and stability. At present, NIV is considered to be the first-line therapy for acute exacerbation of COPD with hypercapnia and respiratory acidosis. This method of airway support turned out to be effective in patients after extubation both for the relief of excommunication from a respirator and for prophylaxis and treatment of postextubation respiratory failure. NIV was proven to be successful in patients with a combination of COPD and obstructive sleep apnea (overlap syndrome), in COPD with pneumonia and in postoperative COPD patients who have undergone lung resectional surgery. The efficacy of NIV under intensive care and intensive therapy unit conditions has stimulated the interest to the use of mask ventilation in hospitals and out-patient departments (for a prolonged domestic therapy). This article presents a review of NIV use in patients with COPD during both periods of exacerbation and stability.\",\"PeriodicalId\":43691,\"journal\":{\"name\":\"Byulleten Sibirskoy Meditsiny\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2017-07-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"8\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Byulleten Sibirskoy Meditsiny\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.20538/1682-0363-2017-2-6-19\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Byulleten Sibirskoy Meditsiny","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20538/1682-0363-2017-2-6-19","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 8

摘要

在过去的二十年中,肺部无创通气(NIV)的使用显著改善了严重COPD急性或慢性呼吸衰竭患者在恶化期和稳定期的治疗效果。目前,NIV被认为是COPD急性加重伴高碳酸血症和呼吸性酸中毒的一线治疗方法。事实证明,这种气道支持方法对拔管后的患者有效,既可以缓解呼吸器的沟通障碍,也可以预防和治疗拔管后呼吸衰竭。NIV被证明在COPD和阻塞性睡眠呼吸暂停综合征(重叠综合征)合并患者、COPD合并肺炎患者以及接受肺切除手术的术后COPD患者中是成功的。NIV在重症监护和重症监护室条件下的疗效激发了人们对在医院和门诊部使用口罩通风的兴趣(用于长期的家庭治疗)。本文综述了NIV在COPD患者急性加重期和稳定期的应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Неинвазивная вентиляция легких у больных ХОБЛ, госпитализированных в стационар
The use of noninvasive ventilation (NIV) of lungs during the last two decades significantly improved the results of management of severe COPD patients with acute or chronic respiratory failure during both periods of exacerbation and stability. At present, NIV is considered to be the first-line therapy for acute exacerbation of COPD with hypercapnia and respiratory acidosis. This method of airway support turned out to be effective in patients after extubation both for the relief of excommunication from a respirator and for prophylaxis and treatment of postextubation respiratory failure. NIV was proven to be successful in patients with a combination of COPD and obstructive sleep apnea (overlap syndrome), in COPD with pneumonia and in postoperative COPD patients who have undergone lung resectional surgery. The efficacy of NIV under intensive care and intensive therapy unit conditions has stimulated the interest to the use of mask ventilation in hospitals and out-patient departments (for a prolonged domestic therapy). This article presents a review of NIV use in patients with COPD during both periods of exacerbation and stability.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Byulleten Sibirskoy Meditsiny
Byulleten Sibirskoy Meditsiny MEDICINE, GENERAL & INTERNAL-
CiteScore
0.70
自引率
50.00%
发文量
102
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信